Incyte ($INCY) announced an update on their ongoing clinical study. Incyte Corporation has recently completed a clinical study titled An ...
A comprehensive webpage-based database, named as IMgateway, currently offers rigorous, evidence-based information on the ...
Drug discovery is a high-risk, high-cost endeavor, with over 90% of candidates failing in clinical development. A significant proportion of these failures stem from unresolved biopharmaceutic ...
New AI tool predicts both primary and hidden secondary drug targets across cancers * DeepTarget outperforms leading ...